IPO Details
Bidding Dates
20 Jun '25 - 24 Jun '25
Minimum Investment
₹1,08,800/ 1 Lot (1,600 Shares)
Price Range
₹68-₹72
Maximum Investment
₹1,15,200/ 1 Lot (1,600 Shares)
Retail Discount
To be announced
Issue Size
₹27.00 Cr
Investor category and sub category
Non-institutional Investors (NII) | Qualified Institutional Buyers (QIB) | Retail Individual Investors (RII) |Aakaar Medical Technologies IPO Important Dates
Important dates with respect to IPO allotment and listing
IPO Opening Date
Jun 20, 25
IPO Closing Date
Jun 24, 25
Basis of Allotment
Jun 25, 25
Initiation of Refunds
Jun 26, 25
IPO Listing Date
Jun 27, 25
Aakaar Medical Technologies IPO Subscription Details
| Date | QIB | NII | Retail | Total |
|---|---|---|---|---|
|
Day 1Jun 19, 2025 |
0.00 | 0.01 | 0.08 | 0.04 |
About Aakaar Medical Technologies IPO
Aakaar Medical Technologies IPO is a book-built issue worth ₹27.00 crore, comprising a fresh issue of 37.50 lakh equity shares. The IPO opens for public subscription on June 20, 2025, and will close on June 24, 2025. The basis of allotment is expected to be finalised by June 25, 2025.
Aakaar Medical Technologies is proposed to be listed on NSE SME, with a tentative listing date set for June 27, 2025. The IPO price band is fixed at ₹68 to ₹72 per share. Retail investors can apply for a minimum of one lot, which includes 1,600 shares, requiring an investment of ₹1,08,800.
However, to manage the possibility of oversubscription, bidding at the cutoff price would amount to ₹1,15,200. For HNI applicants, the minimum application size is two lots, or 3,200 shares, amounting to ₹2,30,400.
Indorient Financial Services Limited is the lead manager for the issue, while Bigshare Services Pvt Limited is acting as the registrar. Alacrity Securities Limited has been appointed as the market maker. Investors can refer to the RHP for complete details.
Industry Outlook
- The global medical aesthetics and cosmetic dermatology market was valued at USD 35.9 billion in 2024 and is projected to reach USD 57.4 billion by 2030, growing at a CAGR of 8.1%. This upward trend is driven by rising awareness, technological advancements, and increased demand for anti-aging treatments.
- In India, the industry generated revenue of USD 283.9 million in 2024 and is expected to grow at a CAGR of 13.9% to reach USD 618.8 million by 2030. Factors such as affordability, improved access, and growing middle-class demand are fueling this growth.
- Hair loss affects 50–60% of Indian men aged 30–50 and 35–45% of women, while increasing skin conditions due to pollution and poor hygiene have boosted demand for dermatology solutions.
Aakaar Medical Technologies IPO Objectives
The company plans to allocate the net proceeds from the issuance to the following purposes:
- The company plans to use the IPO proceeds to meet its working capital needs, ensuring smooth day-to-day operations and business expansion.
- The company also aims to use the funds for general corporate purposes, including operational and strategic needs.
About Aakaar Medical Technologies Limited
Aakaar Medical Technologies Limited, founded in 2013 by Mr. Dilip Meswani, is a prominent player in the Indian medical aesthetics and cosmetic devices space. With over 25 years of experience in the aesthetic industry, Mr. Meswani transitioned his earlier proprietary business into this company to strengthen its market presence.
Aakaar focuses on business-to-business (B2B) distribution, catering to dermatologists, plastic surgeons, and aesthetic physicians across India. The company offers a diverse portfolio of medical aesthetic products, including its own brands—both domestically produced and internationally sourced—and reputed imported brands from countries like Korea, Spain, Italy, and Austria.
In FY2025, imported brands accounted for 62.28% of revenue, while own-branded products contributed 37.72%. Own-brand aesthetic products are developed through third-party or loan licensing manufacturing arrangements, while aesthetic devices are either sourced domestically or imported.
The company actively engages in product research, market trend analysis, and concept development through a well-structured ideation process. Aakaar relies on its experienced team to co-develop formulations and prototypes with its manufacturing partners.
Though it does not maintain an in-house R&D setup, Aakaar follows strict development protocols, leveraging industry expertise and regulatory compliance. Its ongoing focus on innovation, customer insights, and structured feasibility evaluations supports the company's growing presence in the evolving aesthetics industry.
How To Check the Allotment Status of Aakaar Medical Technologies IPO?
Steps to check IPO allotment status on Angel One’s app:
- Log in to the Angel One app.
- Go to the IPO Section and then to IPO Orders.
- Select the individual IPO that you had applied for and check the allotment status.
- Angel One will notify you of your IPO allotment status via push notification and email.
How To Apply for the Aakaar Medical Technologies IPO Online?
- Login to Your Angel One Account: Open the Angel One app or website and log in with your credentials.
- Locate the IPO Section: Navigate to the 'IPO' section on the platform.
- Select IPO: Find and select the Aakaar Medical Technologies IPO from the list of open IPOs.
- Enter the Lot Size: Specify the number of lots you want to bid for.
- Submit Your UPI ID: Enter your UPI ID to link your payment method and submit your application.
- Approve Funds: Once you receive the bid request on your UPI app, approve it by entering your UPI PIN.
Contact Details of Aakaar Medical Technologies IPO
Registered office: 801, Heritage Plaza, Telli Galli Cross Road, Andheri (East),
Mumbai – 400 069, Maharashtra, India
Phone:+91 84528 44024
E-mail: companysecretary@aakaarmedical.in
Aakaar Medical Technologies IPO Reservation
|
Investor Category |
Shares Offered |
|
Qualified Institutional Buyers (QIBs) |
17,79,200 (47.42%) |
|
Retail Individual Investors (RIIs) |
12,48,000 (33.26%) |
|
Non-Institutional Investors (NIIs) |
5,36,000 (14.29%) |
|
Market Maker Shares |
1,88,800 (5.03%) |
|
Total Shares |
37,52,000 (100.00%) |
Aakaar Medical Technologies IPO Anchor Investors Details
|
Bid Date  |
June 19, 2025 |
|
Shares Offered  |
10,67,200 |
|
Anchor Portion Size (In Cr.) |
7.68 |
|
Anchor lock-in period expiry date for the remaining shares (90 days) |
September 23, 2025 |
|
Anchor lock-in period end date for 50% shares (30 Days) |
July 25, 2025 |
Aakaar Medical Technologies IPO Promoter Holding
The promoters of the company include Dilip Ramesh Meswani and Bindi Dilip Meswani.
|
Share Holding Pre-Issue |
91.11% |
|
Share Holding Post Issue  |
- |
Note: Equity dilution will be determined by subtracting the Shareholding Post Issue from the Shareholding Pre Issue.
Aakaar Medical Technologies IPO Lot Size
Investors are required to place bids for at least 1,600 shares, and any additional bids must be in multiples of this lot size. The table below outlines the lowest and highest investment limits for both Retail Investors and High Net-worth Individuals (HNIs), specifying the number of shares and corresponding investment amounts.
|
Application |
Lots |
Shares |
Amount |
|
Retail (Min) |
1 |
1,600 |
₹1,08,800 |
|
Retail (Max) |
1 |
1,600 |
₹1,15,200 |
|
HNI (Min) |
2 |
3,200 |
₹2,30,400 |
Key Performance Indicators for Aakaar Medical Technologies IPO
|
KPI |
Value |
|
RoCE (%) |
21.02 |
|
Debt/Equity |
0.98 |
|
RoNW (%) |
33.81 |
|
PAT Margin |
9.81 |
Aakaar Medical Technologies IPO Prospectus
Aakaar Medical Technologies IPO Registrar and Lead Managers
Aakaar Medical Technologies IPO Lead Managers
- Indorient Financial Services Limited
Registrar for Aakaar Medical Technologies IPO
Bigshare Services Private Limited
- Contact Number: +91-22-6263 8200
- Email Address: ipo@bigshareonline.com
Aakaar Medical Technologies IPO Registrar
Financial Performance of Aakaar Medical Technologies Limited
| Particulars | Year ending on March 31, 2025 | Year ending on March 31, 2024 | Year ending on March 31, 2023 |
|---|---|---|---|
| Revenue from Operation (in ₹ lakh) | 6,158.28 | 4,611.10 | 3,278.46 |
| Profit/ (loss) for the year (in ₹ lakh) | 603.95 | 287.02 | 215.32 |
| Earnings per Share (₹) | 6.13 | 3.15 | 2.37 |
| Net Worth (in ₹ lakh) | 2320.28 | 1,252.56 | 965.54 |
| Total Borrowings (in ₹ lakh) | 2273.83 | 1,505.66 | 587.43 |
| Return on Net Worth (RoNW) (%) | 33.81 | 25.88 | 24.35 |
| EBITDA (in ₹ lakh) | 973.69 | 499.89 | 352.86 |
Know before investing
Strengths
8-
Led by experienced leaders with 20+ years in the aesthetics field.
-
Strong customer base of over 5,205 doctors and clinics across India.
-
Wide portfolio with 154 SKUs and 5.41 lakh units sold.
-
Pan-India delivery backed by 21 warehouses through PISPL partnership.
-
The sales team expanded from 53 to 133 by March 2024.
-
Exploring Tier 2 cities like Rajkot, Udaipur, and Ranchi for expansion.
-
Own Brand revenue grew 72.75% CAGR from FY23 to FY25.
-
Collaborates with partners via licensing and distribution agreements.
Risks
8-
Heavy reliance on imported brands exposes business to global risks.
-
Cost volatility in raw materials can reduce profit margins.
-
Dependent on third-party manufacturers for product supply continuity.
-
Product recalls or liability claims may harm brand and finances.
-
Own brand details shared with partners risk intellectual property leakage.
-
Working capital needs rose to ₹3,908.57 lakh in FY25.
-
High revenue concentration in Maharashtra and Karnataka increases location risk.
-
Seasonal demand variations impact profits during early financial year quarters.
Login to Angel One App / Website & click on IPO
Select desired IPO & tap on "Apply"
Enter UPI ID, set quantity/price & submit
Accept mandate on the UPI app to complete the process
Login to Angel One App / Website
Choose IPO section on Home Page
Click IPO Orders
Chose the IPO application you want to view the status for
Aakaar Medical Technologies IPO FAQs
Aakaar Medical Technologies IPO is a book-built issue IPO. It runs from June 20, 2025, to June 24, 2025.
The Basis of Allotment will happen on Wednesday, June 25, 2025.
The IPO subscription window will open on June 20, 2025.
The minimum lot size retail investors can subscribe to is 1 lot, and the lot size is 1,600 shares.
The listing date for Aakaar Medical Technologies IPO is Friday, June 27, 2025.
The issue size of the Aakaar Medical Technologies IPO is up to ₹27.00 crore.
The open and close dates for Aakaar Medical Technologies IPO are from June 20, 2025, to June 24, 2025.
Listing gains cannot be ascertained before the listing of the IPO on the stock exchange.
You will receive a notification once your order is successfully placed with the exchange after the bidding starts.
Bigshare Services Private Limited is the registrar responsible for managing the IPO allotment process and handling investor queries.
Aakaar Medical Technologies IPO is proposed to be listed on the SME platform of the National Stock Exchange (NSE).
- Multiple Submissions: Use different Demat accounts to make multiple applications.
- Higher Price Band Bidding: Opt for bidding at the cut-off price or higher price band.
- Timely Subscription: Ensure you subscribe to the IPO within the specified time frame.
You must complete the payment process by logging in to your UPI handle and approving the payment mandate.
You can submit only one application using your PAN card.
To read Aakaar Medical Technologies Limited’s financial statements, download the IPO’s RHP document.
Pre-apply allows investors to apply for the Aakaar Medical Technologies IPO two days before the subscription period opens, ensuring an early submission of your application.
Your order will be placed when the IPO opens for bidding, and a UPI request will follow within 24 hours.
